Prosecution Insights
Last updated: August 12, 2026

Korea Research Institute of Chemical Technology

12 pending office actions • 8 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
7
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (25%)
8
Medium (67%)
1
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (50%)
§112 only1 (8%)
Double-patenting + other2 (17%)
Multi-statute (no §101)3 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
8% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SINGH, PREM C 1 59.0% +33.1%
BOWMAN, ANDREW J 1 65.6% +13.2%
RAO, SAVITHA M 1 60.6% +30.0%
SZNAIDMAN, MARCOS L 1 37.2% +16.0%
MOORE, JOHN DAVID 1 65.4% +23.5%
NGUYEN, LAUREN 1 54.8% +34.9%
GRIZER, CASSANDRA SENN 1 60.0% +26.7%
TAYLOR, JORDAN W 1 64.0% +39.0%
DOLETSKI, BLAINE G 1 75.0% +8.9%
HAVLIN, ROBERT H 1 51.6% +27.9%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18271640 NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF GRIZER, CASSANDRA SENN 9d
18001333 ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING HAVLIN, ROBERT H
17997151 SARS CORONAVIRUS 2 DIAGNOSTIC KIT INCLUDING RECEPTOR AND ANTIBODY BINDING TO SARS CORONAVIRUS 2 SPIKE PROTEIN BUCKMASTER, MARLENE VRENI

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18290436 CARTILAGE MODEL AS A SUBSTITUTE FOR ANIMAL MODELS AND METHODS FOR EVALUATING EFFECTIVENESS OR TOXICITY OF DRUGS USING THE SAME MOORE, JOHN DAVID 4d overdue
18271640 NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF GRIZER, CASSANDRA SENN 9d
19000611 CATALYST FOR PRODUCING BASIC CHEMICAL RAW MATERIAL FROM DIESEL SINGH, PREM C
18730146 NOVEL ORGANOPLATINUM COMPOUND, METHOD FOR MANUFACTURING SAME, METHOD FOR MANUFACTURING THIN FILM USING SAME, AND METHOD FOR MANUFACTURING HIGH-PERFORMANCE OPTICAL SENSOR FOR DETECTING MID-INFRARED RAYS USING SAME BOWMAN, ANDREW J
18701820 METHOD FOR PRODUCING 5-HALOMETHYLFURFURAL AND SYSTEM THEREFOR RAO, SAVITHA M
18561855 BENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING SAME AS ACTIVE INGREDIENT SZNAIDMAN, MARCOS L
18378233 TRANSMISSIVE WAVELENGTH TUNABLE HYPERSPECTRAL FILTER USING LAYERED TWISTED LIQUID CRYSTAL THIN FILM NGUYEN, LAUREN
18014164 METHOD FOR MANUFACTURING MONO CALCIUM CITRATE BY USING SHELL AND APPLICATION THEREOF TAYLOR, JORDAN W

Top Art Units

Art UnitApps
1672 2
1692 2
1717 1
1628 1
1638 1
2871 1
1738 1
1626 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19000611 CATALYST FOR PRODUCING BASIC CHEMICAL RAW MATERIAL FROM DIESEL SINGH, PREM C §103 Non-Final OA Pending Dec 23, 2024
18730146 NOVEL ORGANOPLATINUM COMPOUND, METHOD FOR MANUFACTURING SAME, METHOD FOR MANUFACTURING THIN FILM USING SAME, AND METHOD FOR MANUFACTURING HIGH-PERFORMANCE OPTICAL SENSOR FOR DETECTING MID-INFRARED RAYS USING SAME BOWMAN, ANDREW J 1717 §112 Non-Final OA Pending Jul 18, 2024
18701820 METHOD FOR PRODUCING 5-HALOMETHYLFURFURAL AND SYSTEM THEREFOR RAO, SAVITHA M §103 Non-Final OA Pending Apr 16, 2024
18561855 BENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING SAME AS ACTIVE INGREDIENT SZNAIDMAN, MARCOS L 1628 §102DP Non-Final OA Pending Nov 17, 2023
18290436 CARTILAGE MODEL AS A SUBSTITUTE FOR ANIMAL MODELS AND METHODS FOR EVALUATING EFFECTIVENESS OR TOXICITY OF DRUGS USING THE SAME MOORE, JOHN DAVID 1638 §103 Final Rejection 4d overdue Pending Nov 13, 2023
18378233 TRANSMISSIVE WAVELENGTH TUNABLE HYPERSPECTRAL FILTER USING LAYERED TWISTED LIQUID CRYSTAL THIN FILM NGUYEN, LAUREN 2871 §103 Final Rejection Pending Oct 10, 2023
18271640 NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF GRIZER, CASSANDRA SENN 1672 §103§112 Final Rejection 9d Pending Jul 10, 2023
18014164 METHOD FOR MANUFACTURING MONO CALCIUM CITRATE BY USING SHELL AND APPLICATION THEREOF TAYLOR, JORDAN W 1738 §103 Non-Final OA Pending Jan 02, 2023
18011733 EFFICIENT DEPOLYMERIZATION METHOD OF POLYMERS COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF DOLETSKI, BLAINE G 1692 §103 Non-Final OA Pending Dec 20, 2022
18001333 ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING HAVLIN, ROBERT H 1626 §102§103 Final Rejection Pending Dec 09, 2022
17997151 SARS CORONAVIRUS 2 DIAGNOSTIC KIT INCLUDING RECEPTOR AND ANTIBODY BINDING TO SARS CORONAVIRUS 2 SPIKE PROTEIN BUCKMASTER, MARLENE VRENI 1672 §102§112 Final Rejection Pending Oct 26, 2022
17885006 METHOD FOR SIMULTANEOUS CONVERSION OF HYDROGEN SOURCE AND A CARBON DIOXIDE SOURCE INTO FORMATE WITH IMPROVED YIELD RHOADES, DEREK JAMES 1692 §102§103DP Non-Final OA Pending Aug 10, 2022

Managing Korea Research Institute of Chemical Technology's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month